Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barcos

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Leukemia Research|January 1, 1983
Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodiesM Barcos, J Minowada, K Minato, et al.
American Journal of Clinical Oncology|February 1, 1986
Treatment of early--stages I and II--nodular, poorly differentiated lymphocytic lymphomaG A Gomez, M Barcos, R M Krishnamsetty, et al.
Cancer|June 15, 1981
The influence of histologic type on survival in non-Hodgkin's lymphomaM Barcos, R Herrmann, J W Pickren, et al.
Cancer Genetics and Cytogenetics|January 15, 1985
Cytogenetic studies of a diffuse mixed cell lymphoma of T cell originJ Takeuchi, H Ochi, J Minowada, et al.
Cancer|May 1, 1987
Malignant histiocytosis. Complete remission in two pediatric patientsJ H Simon, C K Tebbi, A I Freeman, et al.
Cancer|September 15, 1981
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied casesR S Neiman, M Barcos, C Berard, et al.
Blood|May 23, 1998
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cellsR Sood, C C Stewart, P D Aplan, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Archives of Internal Medicine|September 1, 1986
Primary chemotherapy for localized non-Hodgkin's lymphomas with diffuse histologic characteristics. Preliminary report of a prospective studyG A Gomez, S Reddy, R M Krishnamsetty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group BD R Budman, G R Petroni, J L Johnson, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Leukemia Research|January 1, 1983
Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodiesM Barcos, J Minowada, K Minato, et al.
American Journal of Clinical Oncology|February 1, 1986
Treatment of early--stages I and II--nodular, poorly differentiated lymphocytic lymphomaG A Gomez, M Barcos, R M Krishnamsetty, et al.
Cancer|June 15, 1981
The influence of histologic type on survival in non-Hodgkin's lymphomaM Barcos, R Herrmann, J W Pickren, et al.
Cancer Genetics and Cytogenetics|January 15, 1985
Cytogenetic studies of a diffuse mixed cell lymphoma of T cell originJ Takeuchi, H Ochi, J Minowada, et al.
Cancer|May 1, 1987
Malignant histiocytosis. Complete remission in two pediatric patientsJ H Simon, C K Tebbi, A I Freeman, et al.
Cancer|September 15, 1981
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied casesR S Neiman, M Barcos, C Berard, et al.
Blood|May 23, 1998
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cellsR Sood, C C Stewart, P D Aplan, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Archives of Internal Medicine|September 1, 1986
Primary chemotherapy for localized non-Hodgkin's lymphomas with diffuse histologic characteristics. Preliminary report of a prospective studyG A Gomez, S Reddy, R M Krishnamsetty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group BD R Budman, G R Petroni, J L Johnson, et al.
Pageof 10